SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 657.06 |
Enterprise Value ($M) | 657.06 |
Book Value ($M) | 0.00 |
Book Value / Share | 0.00 |
Price / Book | n/a |
NCAV ($M) | 0.00 |
NCAV / Share | 0.00 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 0.11 |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | n/a |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.00 |
Assets | 0.00 |
Liabilities | 0.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 539.20 |
Operating Income | 77.30 |
Net Income | 58.70 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 85.80 |
Cash from Investing | -15.60 |
Cash from Financing | -16.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
UNBSF – Uni-Bio Science Group Limited | VAXX – Vaxxinity, Inc. |
VCNX – Vaccinex, Inc. | VGLS – VG Life Sciences Inc. |
VICP – Vicapsys Life Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io